See the DrugPatentWatch profile for Imitrex
The generic name for Imitrex is sumatriptan [1].
What is Sumatriptan Used For?
Sumatriptan is used to treat the symptoms of migraine headaches [1]. It is also used for cluster headaches [1].
How Does Sumatriptan Work?
Sumatriptan belongs to a class of drugs called triptans. It works by narrowing blood vessels in the brain [1]. This helps relieve headache symptoms [1].
When Does Sumatriptan Go Off-Patent?
Information on the patent expiry dates for sumatriptan can be found on DrugPatentWatch.com [2].
Who Makes Sumatriptan?
Sumatriptan is available from multiple pharmaceutical companies as a generic medication. Brand-name Imitrex was originally developed by GlaxoSmithKline [3].
What Are the Side Effects of Sumatriptan?
Common side effects of sumatriptan include dizziness, drowsiness, and weakness [1]. Some people may experience tingling or numbness [1]. More serious side effects can include chest pain or tightness, and a feeling of warmth or flushing [1].
Can You Buy Sumatriptan Over-the-Counter?
Sumatriptan is a prescription medication and is not available over-the-counter [1].
What is the Difference Between Sumatriptan and Other Migraine Medications?
Sumatriptan is a triptan, a specific class of migraine medication. Other migraine treatments may include nonsteroidal anti-inflammatory drugs (NSAIDs), or other classes of prescription drugs [4]. Triptans are often used when over-the-counter options are not effective [4].
What Are the Risks of Taking Sumatriptan?
Sumatriptan carries risks, particularly for individuals with certain medical conditions. It should not be used by people with a history of heart disease, uncontrolled high blood pressure, or stroke [1]. Patients should discuss their full medical history with their doctor before starting sumatriptan [1].
---
Sources:
1. Sumatriptan Injection - https://www.drugpatentwatch.com/drug/sumatriptan
2. DrugPatentWatch.com - https://www.drugpatentwatch.com/
3. GlaxoSmithKline - https://www.gsk.com/
4. Migraine Treatment - https://www.drugpatentwatch.com/conditions/migraine-treatment